Literature DB >> 15655534

Captopril improves cerebrovascular structure and function in old hypertensive rats.

François Dupuis1, Jeffrey Atkinson, Patrick Limiñana, Jean-Marc Chillon.   

Abstract

We examined the effects of an angiotensin-converting enzyme inhibitor (ACEI), captopril, on cerebral arterioles in young and old spontaneously hypertensive rats (SHR). Animals were anesthetized with sodium pentobarbitone (60 mg kg(-1) day(-1)). We measured cerebral blood flow (CBF, arbitrary units) and cerebral arteriolar internal diameter (ID, mum) prior to and during stepwise hypotension (SH) in 6- (WKY-6) and 15-month-old (WKY-15) Wistar Kyoto rats and in age-matched SHR that were untreated (SHR-6 and SHR-15) or treated for 3 months with captopril (SHR-6C, 105+/-2 mg kg(-1) day(-1) and SHR-15C, 94+/-1 mg kg(-1) day(-1)). ID and cross-sectional area of the vessel wall (CSA) were measured in deactivated (EDTA) cerebral arterioles during a second SH. Captopril decreased the lower limit of CBF autoregulation (61+/-6 in SHR-6C and 51+/-2 in SHR-15C vs 52+/-6 in WKY-6 and 62+/-7 in WKY-15 and 83+/-14 mmHg in SHR-6 and 120+/-19 mmHg in SHR-15; P<0.05) and CSA (510+/-21 in SHR-6C and 585+/-25 in SHR-15C vs 529+/-12 in WKY-6 and 549+/-20 in WKY-15 and 644+/-38 mmHg in SHR-6 and 704+/-38 mmHg in SHR-15; P<0.05). Captopril increased cerebral arteriolar external diameter of SHR (105+/-5 in SHR-6C and 94+/-4 in SHR-15C vs 125+/-8 in WKY-6 and 108+/-3 in WKY-15 and 83+/-2 mmHg in SHR-6 and 80+/-2 mmHg in SHR-15 for a pial arteriolar pressure step of 35-39 mmHg; P<0.05). Captopril attenuated increases in cerebral arteriolar distensibility in young SHR. Thus, ACEIs attenuate eutrophic and hypertrophic inward remodeling of cerebral arterioles in young and old SHR, thus decreasing the lower limit of CBF autoregulation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15655534      PMCID: PMC1576005          DOI: 10.1038/sj.bjp.0706001

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  34 in total

Review 1.  Cerebrovascular structure and dementia: new drug targets.

Authors:  J Atkinson
Journal:  Trends Pharmacol Sci       Date:  2001-12       Impact factor: 14.819

2.  No effect of angiotensin II AT(2)-receptor antagonist PD 123319 on cerebral blood flow autoregulation.

Authors:  T M Estrup; O B Paulson; S Strandgaard
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2001-09       Impact factor: 1.636

3.  Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats.

Authors:  Y Nishimura; T Ito; J M Saavedra
Journal:  Stroke       Date:  2000-10       Impact factor: 7.914

4.  Adaptive structural changes of the vascular walls in hypertension and their relation to the control of the peripheral resistance.

Authors:  B FOLKOW; G GRIMBY; O THULESIUS
Journal:  Acta Physiol Scand       Date:  1958-12-15

5.  Captopril and quinapril reduce reactive oxygen species.

Authors:  M van der Giet; M Erinola; W Zidek; M Tepel
Journal:  Eur J Clin Invest       Date:  2002-10       Impact factor: 4.686

6.  Structure of cerebral arterioles in cystathionine beta-synthase-deficient mice.

Authors:  Gary L Baumbach; Curt D Sigmund; Teodoro Bottiglieri; Steven R Lentz
Journal:  Circ Res       Date:  2002-11-15       Impact factor: 17.367

7.  Bradykinin mediates the acute effect of an angiotensin-converting enzyme inhibitor on cerebral autoregulation in rats.

Authors:  J Takada; S Ibayashi; T Nagao; H Ooboshi; T Kitazono; M Fujishima
Journal:  Stroke       Date:  2001-05       Impact factor: 7.914

8.  Cerebral arteriolar structure in mice overexpressing human renin and angiotensinogen.

Authors:  Gary L Baumbach; Curt D Sigmund; Frank M Faraci
Journal:  Hypertension       Date:  2003-01       Impact factor: 10.190

9.  Impact of treatment with melatonin on cerebral circulation in old rats.

Authors:  François Dupuis; Olivier Régrigny; Jeffrey Atkinson; Patrick Limiñana; Philippe Delagrange; Elizabeth Scalbert; Jean-Marc Chillon
Journal:  Br J Pharmacol       Date:  2004-01-12       Impact factor: 8.739

10.  Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist.

Authors:  Takeshi Ito; Haruki Yamakawa; Claudia Bregonzio; José A Terrón; Alicia Falcón-Neri; Juan M Saavedra
Journal:  Stroke       Date:  2002-09       Impact factor: 7.914

View more
  14 in total

Review 1.  The effects of obesity on the cerebral vasculature.

Authors:  Anne M Dorrance; Nusrat Matin; Paulo W Pires
Journal:  Curr Vasc Pharmacol       Date:  2014-05       Impact factor: 2.719

Review 2.  Hypertension Induced Morphological and Physiological Changes in Cells of the Arterial Wall.

Authors:  Patricia Martinez-Quinones; Cameron G McCarthy; Stephanie W Watts; Nicole S Klee; Amel Komic; Fabiano B Calmasini; Fernanda Priviero; Alexander Warner; Yu Chenghao; Camilla F Wenceslau
Journal:  Am J Hypertens       Date:  2018-09-11       Impact factor: 2.689

Review 3.  The effects of hypertension on the cerebral circulation.

Authors:  Paulo W Pires; Carla M Dams Ramos; Nusrat Matin; Anne M Dorrance
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-12       Impact factor: 4.733

4.  Neutrophils contribute to intracerebral haemorrhages after treatment with recombinant tissue plasminogen activator following cerebral ischaemia.

Authors:  Sophie Gautier; Thavarak Ouk; Olivier Petrault; Jacques Caron; Régis Bordet
Journal:  Br J Pharmacol       Date:  2009-02-04       Impact factor: 8.739

5.  Cerebrovasculoprotective effects of azilsartan medoxomil in diabetes.

Authors:  Mohammed Abdelsaid; Maha Coucha; Adviye Ergul
Journal:  Transl Res       Date:  2014-06-17       Impact factor: 7.012

Review 6.  Vasotrophic regulation of age-dependent hypoxic cerebrovascular remodeling.

Authors:  Jinjutha Silpanisong; William J Pearce
Journal:  Curr Vasc Pharmacol       Date:  2013-09       Impact factor: 2.719

7.  Metformin ameliorates diabetic nephropathy in a rat model of low-dose streptozotocin-induced diabetes.

Authors:  Siwei Zhang; Huali Xu; Xiaofeng Yu; Yi Wu; Dayun Sui
Journal:  Exp Ther Med       Date:  2017-05-18       Impact factor: 2.447

Review 8.  Recent Progress in Vascular Aging: Mechanisms and Its Role in Age-related Diseases.

Authors:  Xianglai Xu; Brian Wang; Changhong Ren; Jiangnan Hu; David A Greenberg; Tianxiang Chen; Liping Xie; Kunlin Jin
Journal:  Aging Dis       Date:  2017-07-21       Impact factor: 6.745

9.  The rationale and design of the antihypertensives and vascular, endothelial, and cognitive function (AVEC) trial in elderly hypertensives with early cognitive impairment: role of the renin angiotensin system inhibition.

Authors:  Ihab Hajjar; Meaghan Hart; William Milberg; Vera Novak; Lewis Lipsitz
Journal:  BMC Geriatr       Date:  2009-11-18       Impact factor: 3.921

10.  Impact of the neutrophil response to granulocyte colony-stimulating factor on the risk of hemorrhage when used in combination with tissue plasminogen activator during the acute phase of experimental stroke.

Authors:  Sophie Gautier; Thavarak Ouk; Madjid Tagzirt; Catherine Lefebvre; Maud Laprais; Olivier Pétrault; Annabelle Dupont; Didier Leys; Régis Bordet
Journal:  J Neuroinflammation       Date:  2014-05-27       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.